Demographics (2)
- age - Subject age (phv00201704.v2.p1)
- gender - Gender of participant (phv00201705.v2.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for sporadic amyotrophic lateral sclerosis (ALS) (phv00201699.v2.p1)
Race and Ethnicity (1)
- race - Race of participant (phv00201706.v2.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00201711.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00201710.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00201698.v2.p1)
- diagnosis - Diagnosis of participant (phv00201707.v2.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00201713.v2.p1)
- IS_TUMOR - Tumor status (phv00201712.v2.p1)
- PMI - Post-mortem Interval (phv00201708.v2.p1)
- SAMPLE_ID - De-identified Sample ID (phv00201709.v2.p1)
- SAMPLE_ID - Sample ID (phv00201701.v2.p1)
- SAMPLE_USE - Sample use. Seq_DNA_SNP: SNP genotypes derived from sequence data; Seq_DNA_WholeExome: Whole exome sequencing; Seq_RNA_WTSS: Whole transcriptome shotgun sequencing (RNA-seq); Seq_miRNA: Sequencing of microRNA (phv00201702.v2.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00201715.v2.p1)
- SEQUENCING_TYPE - Type of sequencing performed (phv00201714.v2.p1)
- SUBJECT_ID - De-identified Subject ID (phv00201703.v2.p1)
- SUBJECT_ID - Subject ID (phv00201697.v2.p1)
- SUBJECT_ID - Subject ID (phv00201700.v2.p1)